The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $2,917,016.00 cost-plus-fixed-fee contract to Westat, Inc., a for-profit professional services firm, to provide comprehensive clinical site and study monitoring services for the National Center for Complementary and Integrative Health (NCCIH)-funded extramural clinical studies research portfolio.
The original solicitation, which did not have a set-aside designation, was seeking qualified personnel to develop standard operating procedures, training programs, and a quality control plan to support the agency's clinical oversight committees. The contract has a one-year base period with four one-year options and is estimated to involve monitoring up to 50 clinical research sites annually, with approximately 75% of site visits conducted remotely due to COVID-19. This contract appears to be associated with the Cancer Trials Support Unit Indefinite Delivery/Indefinite Quantity (IDIQ) contract that Westat holds with the National Cancer Institute to provide broad-based support services for cancer clinical trials.
Generated 6/6/24, 10:09 AM